𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain

✍ Scribed by Anna-Leena Sirén; Friederike Knerlich; Wolfgang Poser; Christoph H. Gleiter; Wolfgang Brück; Hannelore Ehrenreich


Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
412 KB
Volume
101
Category
Article
ISSN
0001-6322

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Characterization of erythropoietin recep
✍ Jee-Yeong Jeong; Laurie Feldman; Peter Solar; Jolanta Szenajch; Arthur J. Sytkow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 501 KB

## Abstract The identification of erythropoietin receptors (EpoR) on cancer cells has caused concern, since it implies the possibility that treatment of cancer patients with erythropoietin (Epo) and related agents with demonstrable antiapoptotic activity could enhance cancer growth and progression.

Expression of erythropoietin and its rec
✍ Hervé Sartelet; Monique Fabre; Marine Castaing; Jacques Bosq; Ivan Racu; Emeryc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 648 KB

## Abstract ## BACKGROUND. Children with high‐risk neuroblastomas (NB) potentially may benefit from treatment with recombinant human erythropoietin (Epo). Epo is a stimulator of erythropoiesis, acting through its receptor (EpoR). The objective of the current study was to evaluate expression levels

Recombinant human erythropoietin in pedi
✍ Feusner, James ;Hastings, Caroline 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## Background Numerous reports on recombinant human erythropoietin (rHuEPO, epoetin alfa) treatment of cancer‐related anemia in adult patients have been published to date. These have shown that epoetin increases hemoglobin levels, significantly ameliorates symptoms of anemia, and impro